| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |